These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 39286252

  • 1. Case report: Granulocyte-macrophage colony-stimulating factor sargramostim did not rescue the neutrophil phenotype in two patients with JAGN1-mutant severe congenital neutropenia.
    Farmand S, Aydin SE, Wustrau K, Böhm S, Ayuk F, Escherich G, Skokowa J, Müller I, Lehmberg K.
    Front Immunol; 2024; 15():1373495. PubMed ID: 39286252
    [Abstract] [Full Text] [Related]

  • 2. JAGN1 is required for fungal killing in neutrophil extracellular traps: Implications for severe congenital neutropenia.
    Khandagale A, Lazzaretto B, Carlsson G, Sundin M, Shafeeq S, Römling U, Fadeel B.
    J Leukoc Biol; 2018 Dec; 104(6):1199-1213. PubMed ID: 30106500
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The efficacy of single-dose administration of thrombopoietin with coadministration of either granulocyte/macrophage or granulocyte colony-stimulating factor in myelosuppressed rhesus monkeys.
    Neelis KJ, Hartong SC, Egeland T, Thomas GR, Eaton DL, Wagemaker G.
    Blood; 1997 Oct 01; 90(7):2565-73. PubMed ID: 9326222
    [Abstract] [Full Text] [Related]

  • 6. A rare case of syndromic severe congenital neutropenia: JAGN1 mutation.
    Çipe FE, Aydoğmuş Ç, Baskın K, Keskindemirci G, Garncarz W, Boztuğ K.
    Turk J Pediatr; 2020 Oct 01; 62(2):326-331. PubMed ID: 32419428
    [Abstract] [Full Text] [Related]

  • 7. The effect of recombinant human granulocyte/macrophage-colony-stimulating factor (rHu GM-CSF) and rHu G-CSF administration on neutrophil chemiluminescence assay in patients following cyclic chemotherapy.
    Aslan M, Yucel G, Bozcuk H, Savas B.
    Cancer Immunol Immunother; 1998 Nov 01; 47(3):176-81. PubMed ID: 9829843
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjunct to autologous hemopoietic stem cell transplantation for lymphoma.
    Advani R, Chao NJ, Horning SJ, Blume KG, Ahn DK, Lamborn KR, Fleming NC, Bonnem EM, Greenberg PL.
    Ann Intern Med; 1992 Feb 01; 116(3):183-9. PubMed ID: 1345803
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Recombinant human granulocyte-macrophage colony-stimulating factor ameliorates zidovudine-induced neutropenia in patients with acquired immunodeficiency syndrome (AIDS)/AIDS-related complex.
    Levine JD, Allan JD, Tessitore JH, Falcone N, Galasso F, Israel RJ, Groopman JE.
    Blood; 1991 Dec 15; 78(12):3148-54. PubMed ID: 1742482
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Severe congenital neutropenia-associated JAGN1 mutations unleash a calpain-dependent cell death programme in myeloid cells.
    Khandagale A, Holmlund T, Entesarian M, Nilsson D, Kalwak K, Klaudel-Dreszler M, Carlsson G, Henter JI, Nordenskjöld M, Fadeel B.
    Br J Haematol; 2021 Jan 15; 192(1):200-211. PubMed ID: 33206996
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Myelokathexis, a congenital disorder of severe neutropenia characterized by accelerated apoptosis and defective expression of bcl-x in neutrophil precursors.
    Aprikyan AA, Liles WC, Park JR, Jonas M, Chi EY, Dale DC.
    Blood; 2000 Jan 01; 95(1):320-7. PubMed ID: 10607719
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O, Foss B, Petersen H.
    Eur Cytokine Netw; 2001 Jan 01; 12(2):231-8. PubMed ID: 11399510
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.